| Literature DB >> 4840427 |
R Wise, D S Reeves, A S Parker.
Abstract
Ticarcillin was administered to three groups of patients in chronic renal failure; three were undergoing chronic hemodialysis, two were undergoing peritoneal dialysis, and three received the drug after hemodialysis. The serum half-lives were measured. A dosage regime for patients undergoing dialysis is suggested.Entities:
Mesh：
Substances：
Year: 1974 PMID： 4840427 PMCID： PMC428932 DOI： 10.1128/AAC.5.2.119
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191